First-, second- and third-generation CARs replace the extracellular domain with a single-chain variable fragment (scFv) specific to tumor antigens, while their cytoplasmic domain comprises the ζ chain and one (second generation) or two (third generation) costimulatory receptors, such as 4-1BB or CD28 [5–9]. This evidence concerns the gene CD28 and neoplasm.